FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912555175> ?p ?o ?g. }

• W2912555175 abstract "INTRODUCTION: Generic drugs are cost effective alternatives for the brand name drugs and the savings are estimated in the average $8 to $10 billion a year. (Lauren et al., 2009; Information for Consumers). Over the years the prescription of generic drugs has increased substantially (1984:19% & 2009- 60-70%) (IMS health; Information for consumers). Bioequivalence testing is playing a vital role in generic drug development. The generics have to be developed and tested in human subjects by following stringent GCP/GLP standards. From industry point of view, there is a need to conduct bioequivalence studies at an allowable cost to have an effective generic development program in a scientifically acceptable standard. In order to achieve this from time to time various regulatory agencies have issued guidance’s to bring more clarity and uniformity for conducting Bioavailability (BA)/ Bioequivalence (BE) studies.STUDY OBJECTIVES:The basic aim of this project was to study the conductance of BE study, in accordance with the regulatory guidelines. The BE study was conducted on a test product, Zafirlukast and a reference product singuliar.The study objectives included:i. Assessment of the bioavailability of test product A while comparing with a reference product B in 12 healthy, normal, adult, human subjects under fasting conditions.ii. Investigate the source of the observed variability in the Cmax of Test drug.CONCLUSION:All the study procedures followed were in compliance with the protocol and the ICH- GCP guidelines, Declaration of Helsinki and Schedule Y.From the results obtained, in both the fast and the fed study, it is observed that there is no significant difference in the pharmacokinetic parameters, indicating that the bioavailability of drug XY is not affected by food.From the analyses of pharmacokinetic and statistical results it was inferred that, for the ln- transformed data, the 90 % confidence interval about the test to reference ratio of Cmax, AUC0-t and AUC0- of drug XY were falling within the bioequivalence acceptance range of 80.00 % -125.00 %, which demonstrates the bioequivalence of test formulation ‘ZAFIRLUKAST’ with reference formulation ‘SINGULIAR’ under fasting conditions.From the clinical data it can be concluded that the study objectives like the safety and efficacy of the test product has been achieved.Based on clinical, pharmacokinetic and statistical data obtained from healthy, adult, male, human subjects under fasting conditions, it was concluded that a single dose of test formulation ‘ZAFIRLUKAST’ containing drug 1000 mg was found to be safe and bioequivalent to the reference formulation ‘ACCOLATE’ containing drug 1000 mg as90 % confidence interval for the ratios of means of test and reference parameters such as ln-transformed Cmax, AUC0-t and AUC0- of drug is within the bioequivalence acceptance range of 80.00% – 125.00 %." @default.
• W2912555175 created "2019-02-21" @default.
• W2912555175 creator A5078570096 @default.
• W2912555175 date "2016-10-01" @default.
• W2912555175 modified "2023-09-26" @default.
• W2912555175 title "An Open Label Two Way Two Period Randomised Single Dose Comparitive Oral Bioavailability study of Zafirlukast in Healthy Volunteers Under Fasting Conditions" @default.
• W2912555175 hasPublicationYear "2016" @default.
• W2912555175 type Work @default.
• W2912555175 sameAs 2912555175 @default.
• W2912555175 citedByCount "0" @default.
• W2912555175 crossrefType "dissertation" @default.
• W2912555175 hasAuthorship W2912555175A5078570096 @default.
• W2912555175 hasConcept C126322002 @default.
• W2912555175 hasConcept C142724271 @default.
• W2912555175 hasConcept C181389837 @default.
• W2912555175 hasConcept C204787440 @default.
• W2912555175 hasConcept C22979827 @default.
• W2912555175 hasConcept C2426938 @default.
• W2912555175 hasConcept C2776042228 @default.
• W2912555175 hasConcept C2776396487 @default.
• W2912555175 hasConcept C2776452501 @default.
• W2912555175 hasConcept C2780035454 @default.
• W2912555175 hasConcept C2780385302 @default.
• W2912555175 hasConcept C2780815506 @default.
• W2912555175 hasConcept C42404028 @default.
• W2912555175 hasConcept C71924100 @default.
• W2912555175 hasConcept C98274493 @default.
• W2912555175 hasConceptScore W2912555175C126322002 @default.
• W2912555175 hasConceptScore W2912555175C142724271 @default.
• W2912555175 hasConceptScore W2912555175C181389837 @default.
• W2912555175 hasConceptScore W2912555175C204787440 @default.
• W2912555175 hasConceptScore W2912555175C22979827 @default.
• W2912555175 hasConceptScore W2912555175C2426938 @default.
• W2912555175 hasConceptScore W2912555175C2776042228 @default.
• W2912555175 hasConceptScore W2912555175C2776396487 @default.
• W2912555175 hasConceptScore W2912555175C2776452501 @default.
• W2912555175 hasConceptScore W2912555175C2780035454 @default.
• W2912555175 hasConceptScore W2912555175C2780385302 @default.
• W2912555175 hasConceptScore W2912555175C2780815506 @default.
• W2912555175 hasConceptScore W2912555175C42404028 @default.
• W2912555175 hasConceptScore W2912555175C71924100 @default.
• W2912555175 hasConceptScore W2912555175C98274493 @default.
• W2912555175 hasLocation W29125551751 @default.
• W2912555175 hasOpenAccess W2912555175 @default.
• W2912555175 hasPrimaryLocation W29125551751 @default.
• W2912555175 hasRelatedWork W2032971226 @default.
• W2912555175 hasRelatedWork W2110178698 @default.
• W2912555175 hasRelatedWork W2160787317 @default.
• W2912555175 hasRelatedWork W2318220094 @default.
• W2912555175 hasRelatedWork W2350811802 @default.
• W2912555175 hasRelatedWork W2561923293 @default.
• W2912555175 hasRelatedWork W2602974295 @default.
• W2912555175 hasRelatedWork W2740056803 @default.
• W2912555175 hasRelatedWork W2770748138 @default.
• W2912555175 hasRelatedWork W2786349974 @default.
• W2912555175 hasRelatedWork W2792793031 @default.
• W2912555175 hasRelatedWork W2886918870 @default.
• W2912555175 hasRelatedWork W2902164115 @default.
• W2912555175 hasRelatedWork W3022003245 @default.
• W2912555175 hasRelatedWork W3089081291 @default.
• W2912555175 hasRelatedWork W3089081386 @default.
• W2912555175 hasRelatedWork W3138847596 @default.
• W2912555175 hasRelatedWork W3166892486 @default.
• W2912555175 hasRelatedWork W3187116648 @default.
• W2912555175 hasRelatedWork W77378843 @default.
• W2912555175 isParatext "false" @default.
• W2912555175 isRetracted "false" @default.
• W2912555175 magId "2912555175" @default.
• W2912555175 workType "dissertation" @default.